CIViC
Compass
Tumors
Genes
Variants
Evidence
Assertions
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home
/
Biomarker
BRAF V600E — anti-EGFR resistance (colorectal)
Gene:
BRAF
· Type:
mutation
Indications: Colorectal cancer
Sensitivity
Resistance
CIViC Context
FDA Resistance Assertions
Drug
Indication
Recommendation
FDA Source
Link
Cetuximab
Colorectal cancer
NOT RECOMMENDED
FDA Label
Label
Panitumumab
Colorectal cancer
NOT RECOMMENDED
FDA Label
Label